DN
Ginkgo Bioworks
DNA·NYSEBoston MAFounded 2008500 employees
Small CapbiotechPublicOncology
Platform: Cell Programming
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (DNA)
Loading DNA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemafotisoran | DNA-9245 | Preclinical | 2 | PRMT5 | NB | ||
| DNA-3921 | DNA-3921 | NDA/BLA | 2 | AHR | PsoriasisRett |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)